CHADDS FORD, Pa., Oct. 31, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that it will relocate its corporate headquarters to a new facility based in Malvern, Pa., by December 2012. The move to a new corporate center, located approximately 18 miles from Chadds Ford, is part of Endo's long-term growth strategy and ongoing transformation into an all-around health solutions company.